The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Effects of inhaled glucocorticoids on bone density in premenopausal women.
Open accessAbstract
BACKGROUND: Inhaled glucocorticoids are the most commonly used medications for the long-term treatment of patients with asthma. Whether long-term therapy with inhaled glucocorticoids reduces bone mass, as oral glucocorticoid therapy does, is controversial. In a three-year prospective study, we examined the relation between the dose of inhaled glucocorticoids and the rate of bone loss in premenopausal women with asthma. METHODS: We studied 109 premenopausal women, 18 to 45 years of age, who had asthma and no known conditions that cause bone loss and who were treated with inhaled triamcinolone acetonide (100 microg per puff). We measured bone density by dual-photon absorptiometry at base line, at six months, and at one, two, and three years. Serum osteocalcin and parathyroid hormone and urinary N-telopeptide, cortisol, and calcium excretion were measured serially. We measured inhaled glucocorticoid use by means of monthly diaries, supported by the use of an automated actuator-monitoring device. RESULTS: Inhaled glucocorticoid therapy was associated with a dose-related decline in bone density at both the total hip and the trochanter of 0.00044 g per square centimeter per puff per year of treatment (P= 0.01 and P=0.005, respectively). No dose-related effect was noted at the femoral neck or the spine. Even after the exclusion of all women who received oral or parenteral glucocorticoids at any time during the study, there was still an association between the decline in bone density and the number of puffs per year of use. Serum and urinary markers of bone turnover or adrenal function did not predict the degree of bone loss. CONCLUSIONS: Inhaled glucocorticoids lead to a dose-related loss of bone at the hip in premenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most universally described skeletal consequence of glucocorticoid therapy is a reduction in BMD, which can lead to increased fracture risk (243-245).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [243]
In the citing paper
“the skeletal response to prednisolone in these rats shared several similarities to changes observed in humans, including significantly decreased BMD (243), histological evidence of increased bone resorption (194), and biochemical evidence of suppressed bone formation (244, 267, 268).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [243]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,997
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,824
Bone density at various sites for prediction of hip fractures
Cummings, S. R., Browner, W., Cummings, S. R., Black, D. M., Nevitt, M. C., Browner, W., Genant, H. K., Cauley, J., Ensrud, K., Scott, J., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92555-8 · Cited by 2,446
Use of Inhaled Corticosteroids and Risk of Fractures
van Staa, T. P., Leufkens, H. G. M., & Cooper, C. C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,297
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Carey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willet, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009158 · Cited by 827
Glucocorticoid-Induced Osteoporosis
Baylink, D. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090509 · Cited by 398
Inhaled corticosteroid use and bone-mineral density in patients with asthma
Wong, C., Walsh, L. J., Smith, C. J., Wisniewski, A. F. Z., Lewis, S., Hubbard, R., Cawte, S. A., Green, D. J., Pringle, M., & Tattersfield, A. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02138-3 · Cited by 361
Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss
Lukert, B. P., Johnson, B. E., & Robinson, R. G. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070909 · Cited by 211
Flagged first, then by citations
Research works printed but not linked: 3
- Packe GE, 1996, J R Coll Physicians Lond, 30, 128
- Egan JJ, 1999, Eur Respir J, 13, 1267
- Rich GM, 1992, J Heart Lung Transplant, 11, 950
Cited by
Sorted by citations
Items 201–300 of 302
Corticóide inalatório: efeitos no crescimento e na supressão adrenal
Arend, E. E., Fischer, G. B., Mocelin, H. T., & Medeiros, L. R. (2005) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132005000400012 · Cited by 7
Glucocorticoid-induced Osteoporosis
Fitzpatrick, L. A. (2003) · doi:10.1007/978-1-4757-4561-0_12 · Cited by 7
Baba, K., SAKAKIBARA, A., Yagi, T., Niwa, S., Wakayama, H., & Takagi, K. (2002) · Respirology · doi:10.1046/j.1440-1843.2002.00389.x · Cited by 6
Glucocorticoid-Induced Osteoporosis
Adler, R. A., Weinstein, R. S., & Saag, K. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00049-2 · Cited by 6
Chandra, A., Rosenzweig, A. B., & Pignolo, R. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-72228-3_1 · Cited by 6
Radenne, F., Verkindre, C., & Tonnel, A. (2004) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(04)71570-3 · Cited by 6
Functional Recovery and Length of Stay After Hip Fracture in Patients Taking Corticosteroids
Monaco, M. D., Vallero, F., Monaco, R. D., Mautino, F., & Cavanna, A. (2004) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000133438.80033.41 · Cited by 6
Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma
Kemp, J. D. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80303-x · Cited by 6
Williams, D. J., Bennett, K., & Feely, J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02218.x · Cited by 6
Inhaled Corticosteroids and Fractures in COPD
Cho, Y. J., & Sin, D. D. (2018) · CHEST Journal · doi:10.1016/j.chest.2017.08.027 · Cited by 6
Lugogo, N. L., Que, L. G., Gilstrap, D. L., & Kraft, M. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00042-7 · Cited by 5
No association between inhaled corticosteroids and whole body DXA in postmenopausal women
Elmståhl, S., Ekström, H., Johnell, O., de Verdier, M. G., & Norjavaara, E. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1255 · Cited by 5
Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma
Heaton, P. C. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624080-00001 · Cited by 5
Toogood, J. H. (2004) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-1-1-28 · Cited by 4
Chapurlat, R. D., & Genant, H. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00069-x · Cited by 4
Skoner, D. P., Golant, A., Norton, A. E., & Stukus, D. R. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.07.032 · Cited by 4
Therapeutic management of allergic diseases
Watelet, J., Gillard, M. R., Benedetti, M. S., Lelièvre, B., & Diquet, B. (2009) · Drug Metabolism Reviews · doi:10.1080/10837450902891204 · Cited by 4
Advances in therapy for adult asthma
Gelfand, E. W. (2008) · Clinical cornerstone · doi:10.1016/s1098-3597(08)80013-0 · Cited by 4
Lima, J. G., Nóbrega, L. H. C., Nóbrega, M. L. C., Rodrigues, A. B., & Pereira, A. F. F. (2002) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302002000200013 · Cited by 4
Incalzi, R. A., Corsonello, A., Pedone, C., Battaglia, S. L., & Bellia, V. (2010) · Aging Health · doi:10.2217/ahe.10.28 · Cited by 4
Exacerbations dans l’asthme : prévention pharmacologique
Grassin‐Delyle, S., & Girodet, P. (2012) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2011.05.018 · Cited by 4
Derk, C. T. (2006) · Postgraduate Medicine · doi:10.3810/pgm.2006.06.1635 · Cited by 4
The use of inhaled corticosteroids in adult asthma
Staresinic, A. G., & Sorkness, C. A. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00032-9 · Cited by 4
Therapeutic margin of budesonide in patients with mild to severe asthma
Skoner, D. E. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80306-5 · Cited by 4
Long-term management of asthma in children: Safety of inhaled corticosteroids
(2002) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(02)80006-9 · Cited by 4
Lugogo, N. L., Que, L. G., Fertel, D., & Kraft, M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00038-9 · Cited by 3
Bone Density and Imaging of Osteoporosis
Chapurlat, R. D., Delmas, P. D., & Genant, H. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00068-x · Cited by 3
Glucocorticoid-induced osteoporosis
Saigal, R., Mathur, V., Prashant, R., Chakraborty, A., & Mittal, V. (2006) · Indian Journal of Rheumatology · doi:10.1016/s0973-3698(10)60517-1 · Cited by 3
Repetition of an Unusual Stress Fracture in an Anorexic Man: A Case Report
Myers, S., Bell, D., Gorman, J., Best, J., & Rooney, J. (2002) · Journal of orthopaedic surgery · doi:10.1177/230949900201000218 · Cited by 3
Han, M. K., & Lazarus, S. C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00044-0 · Cited by 3
Rosenzweig, A. B., & Pignolo, R. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-467-8_1 · Cited by 3
Osteoporosis en la mujer premenopáusica
Peris, P. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcli.2025.106940 · Cited by 3
22. Nutrition and diet-related bone disease in adult kidney transplant recipients
Tantisattamo, E., Ratanasrimetha, P., Shetty, A. A., Ho, B., Ansari, M., Friedewald, J. J., Gallon, L. G., & Bailey, J. L. (2016) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-823-0_22 · Cited by 2
Therapeutic perspectives of exosomes in glucocorticoid-induced osteoarthrosis
Lv, B., Cheng, Z., Yu, Y., Chen, Y., Gan, W., Li, S., Zhao, K., Cao, Y., & Zhang, Y. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.836367 · Cited by 2
Ensuring patient safety: a closer look at glucocorticoid therapy in COPD and asthma
Corlăteanu, A., & Toma, C. (2025) · Exploration of Asthma & Allergy · doi:10.37349/eaa.2025.1009104 · Cited by 2
Primary Care Perspective on Chronic Obstructive Pulmonary Disease Management
Make, B. J., & Belfer, M. H. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.03.2272 · Cited by 2
Peripheral Bone Status In Children With Asthma Evaluated By Digital X-Ray Radiogrammetry
(2006) · The Internet Journal of Radiology · doi:10.5580/2830 · Cited by 2
Bone Mineral Density to Assess Pediatric Bone Health in Drug Development
Maas, B. M., Wang, J., Cooner, F., Green, D. J., Yuan, Y., Yao, L. P., & Burckart, G. J. (2017) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479017709047 · Cited by 2
Artriti olmayan Psoriasis Hastalarinda Kemik Mineral Yoğunluğunun Değerlendirilmesi
Şaş, S., Erdoğan, H. K., & Bulur, İ. (2018) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.433038 · Cited by 2
Glucocorticoid-Induced Bone Loss in Children
Klein, G. L. (2004) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-004-0011-0 · Cited by 2
Tashkin, D. P. (2005) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200506000-00015 · Cited by 2
Glucocorticoid-induced osteoporosis
McDermott, M. T. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00018-8 · Cited by 2
Evaluation and Management of Osteoporosis and Fragility Fractures in The Elderly
Rosenzweig, A. B., & Mishra, R. (2009) · Aging Health · doi:10.2217/ahe.09.58 · Cited by 2
Pharmacogenomics of Asthma Therapies
Raby, B. A., & Israel, E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00091-7 · Cited by 1
Self-citationBone Health in Adolescents with Chronic Disease
Sieke, E. H., & Peebles, R. (2018) · Springer eBooks · doi:10.1007/978-3-319-72880-3_11 · Cited by 1
Drug therapy and role of nutrition.
Gura, K. M., Chan, L. N., Duggan, C., Watkins, J. B., & Walker, W. A. (2003) · Cited by 1
Measurement of bone mineral density in patients with psoriasis vulgaris
Metin Sabancı Baltalimanı Kemik Hastalıkları Eğitim Araştırma Hastanesi Fizik Tedavi Kliniği, İ., & Köse, N. (2013) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/diclemedj.0921.2013.04.0344 · Cited by 1
Osteoporosis asociada a glucocorticoides, una aproximación práctica. Revisión
Yurgaky, J. M., & Ana María Arredondo, G. (2010) · Revista Med · doi:10.18359/rmed.1313 · Cited by 1
Consideraciones especiales en pacientes mayores de 60 años con asma
Lombard, J. R., & Álvarez, M. M. (2009) · NCT Neumología y Cirugía de Tórax · Cited by 1
Singh, V. K., & Kanvaria, P. (2022) · The Indian Journal of Chest Diseases and Allied Sciences · doi:10.5005/ijcdas-52-4-195 · Cited by 1
Inhaled Corticosteroid Therapy for Asthma
Elliott, J. P., Sossong, N. L., Gentile, D. A., Kidd, K. M., Skoner, D. P., Conte, C. E., & Skoner, J. D. (2019) · Springer eBooks · doi:10.1007/978-3-030-05147-1_39 · Cited by 1
Glucocorticoid-induced osteoporosis: pathogenesis and prevention
Красивина, И. Г., Николаевна, Д. Л., Владимирович, Д. Н., & Larina, A. A. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2019-21-126-134 · Cited by 2
Ингаляционные глюкокортикостероиды при хронической обструктивной болезни легких
Avdeev, S. N. (2010) · PULMONOLOGIYA · doi:10.18093/0869-0189-2010-6-109-119 · Cited by 1
Inhaled Corticosteroid Therapy for Asthma
Elliott, J. P., Sossong, N. L., Gentile, D. A., Kidd, K. M., Conte, C. E., Skoner, J. D., & Skoner, D. P. (2018) · Springer eBooks · doi:10.1007/978-3-319-58726-4_39-1 · Cited by 1
Advances in Evaluation and Treatment of Severe Asthma (Part Two)
Fanta, C. H. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.08.004 · Cited by 1
Osteoporosis: Epidemiology and Assessment
Humphrey, M. B., Zahedi, B., Warriner, A. H., Morgan, S., Leder, B. Z., Saag, K. G., & Yu, E. W.-Y. (2023) · Springer eBooks · doi:10.1007/978-3-031-23488-0_40 · Cited by 1
Diagnosis and treatment of osteoporosis
South-Paul, J. E. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545672.014 · Cited by 1
Special Problems in Glucocorticoid Treatment in Children
Wahn, U. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_6 · Cited by 1
Drugs acting on the respiratory tract
Kuhn, M., Joerger, M., & Hartmann, K. (2003) · Side effects of drugs annual · doi:10.1016/s0378-6080(03)80023-5 · Cited by 1
Effects of inhaled steroids on bone mineral density: Are the conclusions misleading?
Eastell, R. (2001) · BoneKEy-Osteovision · doi:10.1138/2001044 · Cited by 1
Section 3, Component 4: Medications
Program, P., & theDiagnosis, T. E. P. O. (2007) · Cited by 1
Prevention and Treatment of Osteoporosis in Managed Care Settings
Hunter, T. S. (2002) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2002.8.1.58 · Cited by 1
Glucocorticoid-Induced Osteoporosis
McDermott, M. T. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05885-8.00009-x · Cited by 1
Corticosteroids—glucocorticoids, inhaled
(2006) · Elsevier eBooks · doi:10.1016/b0-44-451005-2/00933-5 · Cited by 1
National Heart, Lung, and Blood Institute Guidelines: Classification of Asthma Severity
Boushey, H. A., & Venkayya, R. (2003) · doi:10.1007/978-1-4613-1095-2_13
Burr, M. L., & Stone, M. (2005) · Wiley eBooks · doi:10.1002/9780470987377.ch8
Outcomes associated with inhaled corticosteroid use in asthma and COPD: an update
Bhosle, M. J., Shenolikar, R. A., Kulkarni, A. S., & Balkrishnan, R. (2004) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.4.6.645
Severe osteoporosis with vertebral fractures in a young woman with Behcet's disease
Ionescu, R. M. (2005) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2005.473
Ostrom, N. K., & Goergen, B. S. (2006) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2006.06.005
Mortality and morbidity in patients with Addison's disease
Bergthorsdottir, R. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Ghuweri, A. A., Alkhawaldeh, K. M., & Alzraiqat, A. (2014) · Journal of the Royal Medical Services · doi:10.12816/0004539
Avaliação da composição corporal e densidade mineral ósseo em mulheres com artrite reumatóide
da Silva, R. G. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2007.tde-31052007-165929
Developments in Respiratory Medicine—2002
Nyfort‐Hansen, K. S. (2002) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr2002323194
Mennini, F. S., Sciattella, P., Marcellusi, A., Marcobelli, A., Russo, A., & Caputi, A. P. (2015) · SSRN Electronic Journal · doi:10.2139/ssrn.2673651
Elia, M. (2011)
Osteoporosis inducidapor glucocorticoides
Brance, M. L., & Plantalech, L. (2014) · Revista Argentina de Reumatología · doi:10.47196/rar.v25i3.87
(2002) · The Internet Journal of Asthma Allergy and Immunology · doi:10.5580/26cd
Risk Factors for Osteoporotic Vertebral Fracture in Cushing Syndrome
Lee, S.-H., Park, B.-M., Song, K.-S., Lee, S.-K., Yoon, S.-P., Lee, C.-C., Lee, B.-S., & Yang, B.-S. (2017) · Journal of Korean society of spine surgery · doi:10.4184/jkss.2017.24.1.1
INVITED REVIEW SERIES: HOW TO SET UP PULMONARY SUBSPECIALTY SERVICES
Colt, H. G. (2010)
Chen, W., JOHNSON, K., FitzGerald, J. M., Sadatsafavi, M., & Leslie, W. D. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/184937
Al.Obaidy, M. W., Hussien, S. A., & Taha, S. A. A. R. (2018) · Global Journal of Health Science · doi:10.5539/gjhs.v10n9p35
Bodor, N. S., & Buchwald, P. (2012) · Wiley eBooks · doi:10.1002/9781118407738.ch5
Comorbid Metabolic Disorders in Chronic Lung Diseases
Gumeniuk, М. (2019) · Infusion & Chemotherapy · doi:10.32902/2663-0338-2019-3-5-15
Glucocorticoid-induced osteoporosis and Cushing’s syndrome
Saag, K. G., Adler, R. A., & Weinstein, R. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00045-9
Hypertension associated with unhealthy lifestyle and marked by serum cortisol levelsPreprint
Hu, C., Wu, Y., Li, J., Wang, M., Ge, Y., Tkebuchava, T., & Wu, Q. (2021) · Research Square · doi:10.21203/rs.3.rs-824235/v1
Pharmacogenomics of Allergy and Asthma
Munshi, A., Crotti, L. B., Sharma, V., Sharma, S., & Espinoza, L. A. (2013) · Springer eBooks · doi:10.1007/978-81-322-1184-6_24
Skeletal Effects of Glucocorticoids: Basic and Clinical Aspects
CANALIS, E. M. (2005) · Elsevier eBooks · doi:10.1016/b978-012183502-6/50004-3
Inhaled glucocorticoids can cause bone loss in premenopausal women
&NA; (2001) · Reactions Weekly · doi:10.2165/00128415-200108720-00009
Saag, K. G., Morgan, S. L., & Warriner, A. H. (2009) · Springer eBooks · doi:10.1007/978-1-84800-934-9_40
Barnes, P. J. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-09264-4_4
(2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.658
CORTICOSTEROIDS AND PROSTAGLANDINS
(2010) · Elsevier eBooks · doi:10.1016/b978-0-444-53267-1.50005-8
Veränderungen im Knochenstoffwechsel und/oder an der Knochenmatrix
(2008) · Springer eBooks · doi:10.1007/978-3-540-45531-8_6
Veränderungen im Knochenstoffwechsel und/oder an der Knochenmatrix
Freyschmidt, J. (2016) · Springer eBooks · doi:10.1007/978-3-662-48137-0_6
Corticosteroids—glucocorticoids, inhaled
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.00550-3
Pharmacogenomics of Asthma Therapies
Wechsler, M. E., & Israel, E. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05659-5.00093-0
Self-citationCORTICOSTEROIDS AND RELATED DRUGS
(2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53271-8.50004-1
Anastasilakis, A. D., Naciu, A. M., Yavropoulou, M. P., & Paccou, J. (2024) · Revue du Rhumatisme · doi:10.1016/j.rhum.2024.04.004
Hip fracture risk with corticosteroids in patients with COPD: a systematic review and meta-analysisPreprint
Wang, P., Gao, F., Sun, W., Li, Z., Lijun, S., Xu, X., Li, T., Fan, X., & Wu, X. (2021) · Research Square · doi:10.21203/rs.3.rs-238943/v1
Epidural steroid injections and vertebral fracture risk: a systematic review and meta-analysis
Huang, C.-C., Chi, K., Chang, Y. K., & Lin, H.-M. (2026) · European journal of medical research · doi:10.1186/s40001-026-04804-z
Metadata
- Authors
- Israel, E., Banerjee, T. R., Fitzmaurice, G. M., Kotlov, T. V., LaHive, K., & LeBoff, M. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Harvard Pilgrim Health Care (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-09-27
- Volume
- 345
- Issue
- 13
- Pages
- 941-947
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2061819610
- Cited by
- 303
- References
- 25
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 5 · 2019: 3 · 2018: 10 · 2017: 9 · 2016: 11 · 2015: 12 · 2014: 6 · 2013: 6 · 2012: 8
- FWCI
- 32.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (HL0843)
- National Center for Research Resources (M01 RR 02635, M01RR002635)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- inhaled corticosteroids, bone mineral density, bone loss, asthma, premenopausal women, triamcinolone acetonide, dose-response relationship, hip bone, glucocorticoid-induced osteoporosis, bone turnover markers, osteocalcin, parathyroid hormone, urinary N-telopeptide, adrenal function
- MeSH terms
- Administration, Inhalation, Adolescent, Adult, Asthma, Dose-Response Relationship, Drug, Female, Femur, Glucocorticoids, Humans, Lumbar Vertebrae, Middle Aged, Pelvic Bones, Triamcinolone Acetonide, Cohort Studies, Bone Density, Premenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
